228 related articles for article (PubMed ID: 10604968)
21. Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice.
Reszka R; Beck P; Fichtner I; Hentschel M; Richter J; Kreuter J
J Pharmacol Exp Ther; 1997 Jan; 280(1):232-7. PubMed ID: 8996201
[TBL] [Abstract][Full Text] [Related]
22. Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts.
Zamboni WC; Strychor S; Joseph E; Walsh DR; Zamboni BA; Parise RA; Tonda ME; Yu NY; Engbers C; Eiseman JL
Clin Cancer Res; 2007 Dec; 13(23):7217-23. PubMed ID: 18056203
[TBL] [Abstract][Full Text] [Related]
23. Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Mugabe C; Azghani AO; Omri A
J Antimicrob Chemother; 2005 Feb; 55(2):269-71. PubMed ID: 15590716
[TBL] [Abstract][Full Text] [Related]
24. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors.
Laginha KM; Verwoert S; Charrois GJ; Allen TM
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6944-9. PubMed ID: 16203786
[TBL] [Abstract][Full Text] [Related]
25. Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels.
Mourtas S; Duraj S; Fotopoulou S; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):270-6. PubMed ID: 17928204
[TBL] [Abstract][Full Text] [Related]
26. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
Alexiou C; Jurgons R; Schmid RJ; Bergemann C; Henke J; Erhardt W; Huenges E; Parak F
J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824
[TBL] [Abstract][Full Text] [Related]
27. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
28. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
29. Application of purging biotinylated liposomes from plasma to elucidate influx and efflux processes associated with accumulation of liposomes in solid tumors.
Fung VW; Chiu GN; Mayer LD
Biochim Biophys Acta; 2003 Apr; 1611(1-2):63-9. PubMed ID: 12659946
[TBL] [Abstract][Full Text] [Related]
30. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
Alipour M; Halwani M; Omri A; Suntres ZE
Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
[TBL] [Abstract][Full Text] [Related]
32. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
33. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound triggered release of cisplatin from liposomes in murine tumors.
Schroeder A; Honen R; Turjeman K; Gabizon A; Kost J; Barenholz Y
J Control Release; 2009 Jul; 137(1):63-8. PubMed ID: 19303426
[TBL] [Abstract][Full Text] [Related]
35. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
Khan MA; Owais M
J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
[TBL] [Abstract][Full Text] [Related]
36. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacodynamics, pharmacokinetics and tissue distribution of liposomal mitoxantrone hydrochloride].
Wang CX; Li CL; Zhao X; Yang HY; Wei N; Li YH; Zhang L; Zhang L
Yao Xue Xue Bao; 2010 Dec; 45(12):1565-9. PubMed ID: 21351498
[TBL] [Abstract][Full Text] [Related]
38. Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar (PSC 833) with sterically stabilized liposomal doxorubicin.
Krishna R; St-Louis M; Mayer LD
Int J Cancer; 2000 Jan; 85(1):131-41. PubMed ID: 10585596
[TBL] [Abstract][Full Text] [Related]
39. Formation of transition metal-doxorubicin complexes inside liposomes.
Abraham SA; Edwards K; Karlsson G; MacIntosh S; Mayer LD; McKenzie C; Bally MB
Biochim Biophys Acta; 2002 Sep; 1565(1):41-54. PubMed ID: 12225851
[TBL] [Abstract][Full Text] [Related]
40. Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas.
Fang JY; Lee WR; Shen SC; Huang YL
J Dermatol Sci; 2006 May; 42(2):101-9. PubMed ID: 16423506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
